Bioorganic & Medicinal Chemistry Letters 28 (2018) 1001–1004 Contents lists available at ScienceDirect Bioorganic & Medicinal Chemistry Letters journal homepage: www.elsevier.com/locate/bmcl Novel polyamine-based Histone deacetylases-Lysine demethylase 1 dual binding inhibitors a,⇑ b a a c Andrea Milelli , Chiara Marchetti , Eleonora Turrini , Elena Catanzaro , Roberta Mazzone , c a a b Daniela Tomaselli , Carmela Fimognari , Vincenzo Tumiatti , Anna Minarini Department for Life Quality Studies, Alma Mater Studiorum-University of Bologna, Corso d’Augusto 237, 47921 Rimini, Italy Department of Pharmacy and Biotechnology, Alma Mater Studiorum-University of Bologna, Via Belmeloro 6, 40126 Bologna, Italy Department of Drug Chemistry and Technologies, Sapienza University of Rome, P.le Aldo Moro 5, 00185 Roma, Italy article i nfo abstract Article history: Epigenetic modulators Histone deacetylases (HDACs) and Lysine demethylase (LSD1) are validated tar- Received 29 November 2017 gets for anticancer therapy. Both HDAC1/2 and LSD1 are found in association with the repressor protein Revised 15 February 2018 CoREST in a transcriptional co-repressor complex, which is responsible for gene silencing. Combined Accepted 16 February 2018 modulation of both targets results in a synergistic antiproliferative activity. In the present investigation, Available online 17 February 2018 we report about the design and synthesis
Bioorganic & Medicinal Chemistry Letters – Elsevier
Published: Apr 1, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera